Abilify, generically aripiprazole, is used to treat psychotic conditions such as schizophrenia and bipolar disorder. It was first approved for use in the treatment of adult schizophrenia in 2002. In 2004, it was approved for treatment of acute manic and mixed episodes associated with bipolar disorder followed by approval for treatment for major depressive disorder in 2007.
The prescribing sheet for Abilify presently warns of compulsive behaviors, such as excessive shopping and gambling, but the danger was not previously disclosed, despite evidence of the risks existing since the early 2000sf. Studies have shown patients receiving the treatment sometimes engage in compulsive gambling while taking the drug—behavior that was not previously a problem. Further, those who suffered from compulsive drives quickly lost interest in gambling after treatment with aripiprazole stopped. Pathological gambling was the first compulsive behaviors associated with Abilify. However, studies also reported other potentially devastating behaviors. One 2014 study in the Journal of the American Medical Association noted impulse control disorders among those taking dopamine receptor agonist drugs like Abilify, such as pathological gambling, hypersexuality, and compulsive shopping.
In 2016, hundreds of Abilify lawsuits were consolidated into multidistrict litigation (MDL) in the U.S. District Court in the Northern District of Florida. According to the U.S. Judicial Panel on Multidistrict Litigation, there were more than 700 cases pending in the MDL as of March 2018. However, due to applicable statutes of limitations, the deadline to file a claim may be drawing close. Statutes of limitations vary by state, so consulting an experienced attorney to see if your claim is still viable is time sensitive.
If you or a loved one has suffered from compulsive behavior while taking Abilify, contact the experienced dangerous drug attorneys at Neumann Law Group for a free consultation. We will evaluate your claim and determine when the applicable statute of limitations will run.